Has Kyle Song received payments from drug or device companies?

Yes. Drug and device makers reported $16,863 in general payments to Kyle Song across 264 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kyle Song did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kyle Song come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kyle Song

Plastic Surgery · Irvine, CANPI 1366620007

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.4%), consulting fees and other — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Apyx Medical Corporation at 25.0% of the total. Reporting peaked in 2019 at $5,115 and has fallen 56.2% since, to $2,243 in 2025.

$16,863in general payments, 2019–2025

Across 264 payments — averaging $63.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Apyx Medical Corporation$4K
Motiva USA, LLC$4K
Sientra, Inc.$3K
AbbVie$2K
Integra Lifesciences Corporation$2K
Surgical Innovation Associates, Inc.$1K
plus $855 from 9 others

What the payments were for

Consulting fees$5,00030%
Travel & lodging$1,5009%
Food & beverage$7,99147%
Other$2,37314%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Apyx Medical Corporation	14	$4,213
Motiva USA, LLC	32	$3,513
Sientra, Inc.	79	$3,286
AbbVie(2 entities)	98	$1,945
Integra Lifesciences Corporation	20	$1,781
Surgical Innovation Associates, Inc.	2	$1,271
Merz North America, Inc.	4	$347
TELA Bio, Inc.	2	$186
Galderma Laboratories, L.p.	6	$102
Mentor Worldwide LLC	2	$95
Musculoskeletal Transplant Foundation Inc.	1	$34
Baxter Healthcare	1	$33
Pacira Pharmaceuticals Incorporated	1	$23
Vertical Pharmaceuticals, LLC	1	$22
Revance Therapeutics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Motiva Implant Matrix$2,902
DuraSorb Monofilament Mesh$2,510
SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$1,693
XEOMIN$163
NATRELLE SALINE-FILLED BREAST IMPLANTS$104

How this compares

$16,863 in reported general payments places this provider in the 85th percentile of 780 plastic surgery providers in California.

See all plastic surgery providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Scopolamine	16	$139
Cephalexin	16	$62

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Irvine

Ali QureshiIrvine$81K
Tenley LawtonIrvine$39K
Rahm NazeraliPalo Alto$1.5M
Vipul DevBakersfield$1.1M
Arash MomeniPalo Alto$836K
Anne PeledSan Francisco$570K
Salvatore PacellaSan Diego$517K
Hani SbitanySan Francisco$510K
John ApostolidesSan Diego$460K
Garrett WirthNewport Beach$362K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →